New insights into upper airway innate immunity

American Journal of Rhinology and Allergy

Volumn 30, Issue 5, 2016, Pages 319-323

  Hariri, Benjamin M ^a   Cohen, Noam A ^a,b,c  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c MONELL CHEMICAL SENSES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DEFENSIN; RADICAL;

BITTER TASTE; CHRONIC RHINOSINUSITIS; CONFERENCE PAPER; CYSTIC FIBROSIS; EPITHELIUM CELL; HUMAN; IMMUNOMODULATION; INNATE IMMUNITY; MUCOCILIARY CLEARANCE; NOSE CAVITY; REGULATORY MECHANISM; SECRETION (PROCESS); SWEETNESS; TASTE BUD; UPPER RESPIRATORY TRACT; ANIMAL; CHRONIC DISEASE; IMMUNOLOGY; NOSE MUCOSA; PARANASAL SINUS; RESPIRATORY SYSTEM; RHINITIS; SINUSITIS; TASTE;

ANIMALS; CHRONIC DISEASE; EPITHELIAL CELLS; HUMANS; IMMUNITY, INNATE; MUCOCILIARY CLEARANCE; NASAL MUCOSA; PARANASAL SINUSES; RESPIRATORY SYSTEM; RHINITIS; SINUSITIS; TASTE;

EID: 84986880488     PISSN: 19458924     EISSN: 19458932     Source Type: Journal    
DOI: 10.2500/ajra.2016.30.4360     Document Type: Conference Paper

References (85)

1. Blalock JE. The immune system as the sixth sense. J Intern Med 257:126-138, 2005.
2. Blalock JE, and Smith EM. Conceptual development of the immune system as a sixth sense. Brain Behav Immun 21:23-33, 2007.
3. Bedford FL. The missing sense modality: The immune system. Perception 40:1265-1267, 2011.
4. Lee RJ, and Cohen NA. Sinonasal solitary chemosensory cells "taste" the upper respiratory environment to regulate innate immunity. Am J Rhinol Allergy 28:366-373, 2014.
5. Stevens WW, Lee RJ, Schleimer RP, and Cohen NA. Chronic rhinosinusitis pathogenesis. J Allergy Clin Immunol 136:1442-1453, 2015.
6. Orlandi RR, Kingdom TT, Hwang PH, et al. International Consensus Statement on Allergy and Rhinology: Rhinosinusitis. Int Forum Allergy Rhinol 6(suppl. 1):S22-S209, 2016.
7. Fokkens WJ, Lund VJ, Mullol J, et al. European Position Paper on Rhinosinusitis and Nasal Polyps 2012. Rhinol Suppl 2012:3 p preceding table of contents 1-298, 2012.
8. Bhattacharyya N. Incremental health care utilization and expenditures for chronic rhinosinusitis in the United States. Ann Otol Rhinol Laryngol 120:423-427, 2011.
9. Bhattacharyya N, Grebner J, and Martinson NG. Recurrent acute rhinosinusitis: Epidemiology and health care cost burden. Otolaryngol Head Neck Surg 146:307-312, 2012.
10. Ivanov II, Frutos Rde L, Manel N, et al. Specific microbiota direct the differentiation of IL-17-producing T-helper cells in the mucosa of the small intestine. Cell Host Microbe 4:337-349, 2008.
11. Soyka MB, Wawrzyniak P, Eiwegger T, et al. Defective epithelial barrier in chronic rhinosinusitis: The regulation of tight junctions by IFN-gamma and IL-4. J Allergy Clin Immunol 130:1087-1096.e10, 2012.
12. Nomura K, Obata K, Keira T, et al. Pseudomonas aeruginosa elastase causes transient disruption of tight junctions and downregulation of PAR-2 in human nasal epithelial cells. Respir Res 15:21, 2014.
13. Malik Z, Roscioli E, Murphy J, et al. Staphylococcus aureus impairs the airway epithelial barrier in vitro. Int Forum Allergy Rhinol 5:551-556, 2015.
14. Rudack C, Steinhoff M, Mooren F, et al. PAR-2 activation regulates IL-8 and GRO-alpha synthesis by NF-kappaB, but not RANTES, IL-6, eotaxin or TARC expression in nasal epithelium. Clin Exp Allergy 37:1009-1022, 2007.
15. Ossovskaya VS, and Bunnett NW. Protease-activated receptors: contribution to physiology and disease. Physiol Rev 84:579-621, 2004.
16. Kirkham S, Sheehan JK, Knight D, et al. Heterogeneity of airways mucus: Variations in the amounts and glycoforms of the major oligomeric mucins MUC5AC and MUC5B. Biochem J 361:537-546, 2002.
17. Martinez-Anton A, Debolos C, Garrido M, et al. Mucin genes have different expression patterns in healthy and diseased upper airway mucosa. Clin Exp Allergy 36:448-457, 2006.
18. Jackson AD. Airway goblet-cell mucus secretion. Trends Pharmacol Sci 22:39-45, 2001.
19. Groneberg DA, Peiser C, Dinh QT, et al. Distribution of respiratory mucin proteins in human nasal mucosa. Laryngoscope 113:520-524, 2003.
20. Rogers DF. The airway goblet cell. Int J Biochem Cell Biol 35:1-6, 2003.
21. Workman AD, and Cohen NA. The effect of drugs and other compounds on the ciliary beat frequency of human respiratory epithelium. Am J Rhinol Allergy 28:454-464, 2014.
22. Lee RJ, and Foskett JK. Ca2+ signaling and fluid secretion by secretory cells of the airway epithelium. Cell Calcium 55:325-336, 2014.
23. Lee RJ, Xiong G, Kofonow JM, et al. T2R38 taste receptor polymorphisms underlie susceptibility to upper respiratory infection. J Clin Invest 122:4145-4159, 2012.
24. Zhao KQ, Cowan AT, Lee RJ, et al. Molecular modulation of airway epithelial ciliary response to sneezing. FASEB J 26:3178-3187, 2012.
25. Mall MA, and Galietta LJ. Targeting ion channels in cystic fibrosis. J Cyst Fibros 14:561-570, 2015.
26. Illing EA, and Woodworth BA. Management of the upper airway in cystic fibrosis. Curr Opin Pulm Med 20:623-631, 2014.
27. Seshadri S, Lu X, Purkey MR, et al. Increased expression of the epithelial anion transporter pendrin/SLC26A4 in nasal polyps of patients with chronic rhinosinusitis. J Allergy Clin Immunol 136:1548-1558.e1-7, 2015.
28. Gudis DA, and Cohen NA. Cilia dysfunction. Otolaryngol Clin North Am 43:461-472, vii, 2010.
29. Gudis D, Zhao KQ, and Cohen NA. Acquired cilia dysfunction in chronic rhinosinusitis. Am J Rhinol Allergy 26:1-6, 2012.
30. Blount A, Zhang S, Chestnut M, et al. Transepithelial ion transport is suppressed in hypoxic sinonasal epithelium. Laryngoscope 121:1929-1934, 2011.
31. Shin HW, Cho K, Kim DW, et al. Hypoxia-inducible factor 1 mediates nasal polypogenesis by inducing epithelial-to-mesenchymal transition. Am J Respir Crit Care Med 185:944-954, 2012.
32. Baroody FM. Mucociliary transport in chronic rhinosinusitis. Clin Allergy Immunol 20:103-119, 2007.
33. Pahl A, Szelenyi S, and Brune K. Hypoxia induced chemokine expression in nasal epithelial cells: Development of an in vitro model for chronic rhinosinusitis. ALTEX 23:59-63, 2006.
34. Steinke JW, Woodard CR, and Borish L. Role of hypoxia in inflammatory upper airway disease. Curr Opin Allergy Clin Immunol 8:16-20, 2008.
35. Lee RJ, and Cohen NA. Taste receptors in innate immunity. Cell Mol Life Sci 72:217-236, 2015.
36. Hankiewicz J, and Swierczek E. Lysozyme in human body fluids. Clin Chim Acta 57:205-209, 1974.
37. Klockars M, and Reitamo S. Tissue distribution of lysozyme in man. J Histochem Cytochem 23:932-940, 1975.
38. Yoshimura K, Toibana A, and Nakahama K. Human lysozyme: Sequencing of a cDNA, and expression and secretion by Saccharomyces cerevisiae. Biochem Biophys Res Commun 150:794-801, 1988.
39. Nash JA, Ballard TN, Weaver TE, and Akinbi HT. The peptidoglycandegrading property of lysozyme is not required for bactericidal activity in vivo. J Immunol 177:519-526, 2006.
40. Prokhorenko IR, Zubova SV, Ivanov AY, and Grachev SV. Interaction of Gram-negative bacteria with cationic proteins: Dependence on the surface characteristics of the bacterial cell. Int J Gen Med 2:33-38, 2009.
41. Woods CM, Hooper DN, Ooi EH, et al. Human lysozyme has fungicidal activity against nasal fungi. Am J Rhinol Allergy 25:236-240, 2011.
42. Parker D, and Prince A. Innate immunity in the respiratory epithelium. Am J Respir Cell Mol Biol 45:189-201, 2011.
43. Howard DH. Acquisition, transport, and storage of iron by pathogenic fungi. Clin Microbiol Rev 12:394-404, 1999.
44. Philpott CC. Iron uptake in fungi: A system for every source. Biochim Biophys Acta 1763:636-645, 2006.
45. Singh PK, Parsek MR, Greenberg EP, and Welsh MJ. A component of innate immunity prevents bacterial biofilm development. Nature 417:552-555, 2002.
46. Legrand D. Lactoferrin, a key molecule in immune and inflammatory processes. Biochem Cell Biol 90:252-268, 2012.
47. Ellison RT III, and Giehl TJ. Killing of gram-negative bacteria by lactoferrin and lysozyme. J Clin Invest 88:1080-1091, 1991.
48. Psaltis AJ, Wormald PJ, Ha KR, and Tan LW. Reduced levels of lactoferrin in biofilm-associated chronic rhinosinusitis. Laryngoscope 118:895-901, 2008.
49. Ganz T. Defensins: Antimicrobial peptides of innate immunity. Nat Rev Immunol 3:710-720, 2003.
50. Wilson SS, Wiens ME, and Smith JG. Antiviral mechanisms of human defensins. J Mol Biol 425:4965-4980, 2013.
51. Feng Z, Jiang B, Chandra J, et al. Human beta-defensins: differential activity against candidal species and regulation by Candida albicans. J Dent Res 84:445-450, 2005.
52. Bai X, Tian T, Wang P, et al. Potential roles of placental human beta-defensin-3 and apolipoprotein B mRNA-editing enzyme catalytic polypeptide 3G in prevention of intrauterine transmission of hepatitis B virus. J Med Virol 87:375-379, 2015.
53. Proud D, Sanders SP, and Wiehler S. Human rhinovirus infection induces airway epithelial cell production of human beta-defensin 2 both in vitro and in vivo. J Immunol 172:4637-4645, 2004.
54. Harder J, Meyer-Hoffert U, Teran LM, et al. Mucoid Pseudomonas aeruginosa, TNF-alpha, and IL-1beta, but not IL-6, induce human beta-defensin-2 in respiratory epithelia. Am J Respir Cell Mol Biol 22:714-721, 2000.
55. Chennupati SK, Chiu AG, Tamashiro E, et al. Effects of an LL-37-derived antimicrobial peptide in an animal model of biofilm Pseudomonas sinusitis. Am J Rhinol Allergy 23:46-51, 2009.
56. Bals R, Weiner DJ, Meegalla RL, and Wilson JM. Transfer of a cathelicidin peptide antibiotic gene restores bacterial killing in a cystic fibrosis xenograft model. J Clin Invest 103:1113-1117, 1999.
57. Golec M. Cathelicidin LL-37: LPS-neutralizing, pleiotropic peptide. Ann Agric Environ Med 14:1-4, 2007.
58. Yim S, Dhawan P, Ragunath C, et al. Induction of cathelicidin in normal and CF bronchial epithelial cells by 1, 25-dihydroxyvitamin D (3). J Cyst Fibros 6:403-410, 2007.
59. Sultan B, Ramanathan M Jr, Lee J, et al. Sinonasal epithelial cells synthesize active vitamin D, augmenting host innate immune function. Int Forum Allergy Rhinol 3:26-30, 2013.
60. Hansdottir S, and Monick MM. Vitamin D effects on lung immunity and respiratory diseases. Vitam Horm 86:217-237, 2011.
61. Akbar NA, and Zacharek MA. Vitamin D: Immunomodulation of asthma, allergic rhinitis, and chronic rhinosinusitis. Curr Opin Otolaryngol Head Neck Surg 19:224-228, 2011.
62. Mulligan JK, Bleier BS, O'Connell B, et al. Vitamin D3 correlates inversely with systemic dendritic cell numbers and bone erosion in chronic rhinosinusitis with nasal polyps and allergic fungal rhinosinusitis. Clin Exp Immunol 164:312-320, 2011.
63. Mulligan JK, White DR, Wang EW, et al. Vitamin D3 deficiency increases sinus mucosa dendritic cells in pediatric chronic rhinosinusitis with nasal polyps. Otolaryngol Head Neck Surg 147:773-781, 2012.
64. Bacchetta J, Salusky IB, and Hewison M. Beyond mineral metabolism, is there an interplay between FGF23 and vitamin D in innate immunity? Pediatr Nephrol 28:577-582, 2013.
65. Maniscalco M, Sofia M, and Pelaia G. Nitric oxide in upper airways inflammatory diseases. Inflamm Res 56:58-69, 2007.
66. Degano B, Valmary S, Serrano E, et al. Expression of nitric oxide synthases in primary ciliary dyskinesia. Hum Pathol 42:1855-1861, 2011.
67. Knight JA. Review: Free radicals, antioxidants, and the immune system. Ann Clin Lab Sci 30:145-158, 2000.
68. Yoon SS, Coakley R, Lau GW, et al. Anaerobic killing of mucoid Pseudomonas aeruginosa by acidified nitrite derivatives under cystic fibrosis airway conditions. J Clin Invest 116:436-446, 2006.
69. Major TA, Panmanee W, Mortensen JE, et al. Sodium nitrite-mediated killing of the major cystic fibrosis pathogens Pseudomonas aeruginosa, Staphylococcus aureus, and Burkholderia cepacia under anaerobic planktonic and biofilm conditions. Antimicrob Agents Chemother 54:4671-4677, 2010.
70. Vareille M, Kieninger E, Edwards MR, and Regamey N. The airway epithelium: Soldier in the fight against respiratory viruses. Clin Microbiol Rev 24:210-229, 2011.
71. MacMicking JD, Nathan C, Hom G, et al. Altered responses to bacterial infection and endotoxic shock in mice lacking inducible nitric oxide synthase. Cell 81:641-650, 1995.
72. Fang FC. Perspectives series: Host/pathogen interactions. Mechanisms of nitric oxide-related antimicrobial activity. J Clin Invest 99:2818-2825, 1997.
73. Grasemann H, and Ratjen F. Nitric oxide and L-arginine deficiency in cystic fibrosis. Curr Pharm Des 18:726-736, 2012.
74. Nathan C. Inducible nitric oxide synthase: What difference does it make? J Clin Invest 100:2417-2423, 1997.
75. Detwiller KY, Smith TL, Alt JA, et al. Differential expression of innate immunity genes in chronic rhinosinusitis. Am J Rhinol Allergy 28:374-377, 2014.
76. Lee RJ, Kofonow JM, Rosen PL, et al. Bitter and sweet taste receptors regulate human upper respiratory innate immunity. J Clin Invest 124:1393-1405, 2014.
77. Lee RJ, and Cohen NA. Bitter and sweet taste receptors in the respiratory epithelium in health and disease. J Mol Med (Berl) 92:1235-1244, 2014.
78. Lee RJ, and Cohen NA. The emerging role of the bitter taste receptor T2R38 in upper respiratory infection and chronic rhinosinusitis. Am J Rhinol Allergy 27:283-286, 2013.
79. Farquhar DR, Kovatch KJ, Palmer JN, et al. Phenylthiocarbamide taste sensitivity is associated with sinonasal symptoms in healthy adults. Int Forum Allergy Rhinol 5:111-118, 2015.
80. Adappa ND, Zhang Z, Palmer JN, et al. The bitter taste receptor T2R38 is an independent risk factor for chronic rhinosinusitis requiring sinus surgery. Int Forum Allergy Rhinol 4:3-7, 2014.
81. Adappa ND, Howland TJ, Palmer JN, et al. Genetics of the taste receptor T2R38 correlates with chronic rhinosinusitis necessitating surgical intervention. Int Forum Allergy Rhinol 3:184-187, 2013.
82. Mfuna Endam L, Filali-Mouhim A, Boisvert P, et al. Genetic variations in taste receptors are associated with chronic rhinosinusitis: A replication study. Int Forum Allergy Rhinol 4:200-206, 2014.
83. Pezzulo AA, Gutierrez J, Duschner KS, et al. Glucose depletion in the airway surface liquid is essential for sterility of the airways. PLoS One 6:e16166, 2011.
84. Hatten KM, Palmer JN, Lee RJ, et al. Corticosteroid use does not alter nasal mucus glucose in chronic rhinosinusitis. Otolaryngol Head Neck Surg 152:1140-1144, 2015.
85. Zhang Z, Adappa ND, Lautenbach E, et al. The effect of diabetes mellitus on chronic rhinosinusitis and sinus surgery outcome. Int Forum Allergy Rhinol 4:315-320, 2014.